Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic.
Reger M, Manz K, Kaeuferle T, Coffey R, Wotschofsky Z, von Luettichau I, Schlegel PG, Frühwald MC, Corbacioglu S, Metzler M, Feuchtinger T. Reger M, et al. Among authors: von luettichau i. Pediatr Hematol Oncol. 2024 Oct;41(7):504-518. doi: 10.1080/08880018.2024.2393623. Epub 2024 Sep 5. Pediatr Hematol Oncol. 2024. PMID: 39235390 Free article.
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: von luettichau i. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Effects of strength exercise interventions on activities of daily living, motor performance, and physical activity in children and adolescents with leukemia or non-Hodgkin lymphoma: Results from the randomized controlled ActiveADL Study.
Gaser D, Peters C, Oberhoffer-Fritz R, Götte M, Feuchtinger T, Schmid I, Haller B, von Luettichau I, Kesting S. Gaser D, et al. Among authors: von luettichau i. Front Pediatr. 2022 Nov 8;10:982996. doi: 10.3389/fped.2022.982996. eCollection 2022. Front Pediatr. 2022. PMID: 36425395 Free PMC article.
Availability and adaption of exercise programs in pediatric oncology during the COVID-19 pandemic and beyond: a nationwide follow-up survey of providers in Germany.
Kesting S, Gaser D, Queisser J, Götte M, von Luettichau I, Peters C, Oberhoffer-Fritz R, Gauß G. Kesting S, et al. Among authors: von luettichau i. Front Pediatr. 2024 Mar 22;12:1372261. doi: 10.3389/fped.2024.1372261. eCollection 2024. Front Pediatr. 2024. PMID: 38586153 Free PMC article.
Early clinical trial unit tumor board: a real-world experience in a national cancer network.
Weiss L, Dorman K, Boukovala M, Schwinghammer F, Jordan P, Fey T, Hasselmann K, Subklewe M, Bücklein V, Bargou R, Goebeler M, Sayehli C, Spoerl S, Lüke F, Heudobler D, Claus R, von Luettichau I, Lorenzen S, Lange S, Westphalen CB, von Bergwelt-Baildon M, Heinemann V, Gießen-Jung C. Weiss L, et al. Among authors: von luettichau i. J Cancer Res Clin Oncol. 2023 Nov;149(14):13383-13390. doi: 10.1007/s00432-023-05196-x. Epub 2023 Jul 25. J Cancer Res Clin Oncol. 2023. PMID: 37490102 Free PMC article.
Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.
Prexler C, Knape MS, Erlewein-Schweizer J, Roll W, Specht K, Woertler K, Weichert W, von Luettichau I, Rossig C, Hauer J, Richter GHS, Weber W, Burdach S. Prexler C, et al. Among authors: von luettichau i. Cancers (Basel). 2022 Dec 5;14(23):5999. doi: 10.3390/cancers14235999. Cancers (Basel). 2022. PMID: 36497479 Free PMC article.
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
Bielack SS, Blattmann C, Borkhardt A, Csóka M, Hassenpflug W, Kabíčková E, Kager L, Kessler T, Kratz C, Kühne T, Kevric M, Lehrnbecher T, Mayer-Steinacker R, Mettmann V, Metzler M, Reichardt P, Rossig C, Sorg B, von Luettichau I, Windhager R, Hecker-Nolting S. Bielack SS, et al. Among authors: von luettichau i. Eur J Cancer. 2022 Nov;176:50-57. doi: 10.1016/j.ejca.2022.09.007. Epub 2022 Sep 30. Eur J Cancer. 2022. PMID: 36191386
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy.
Schober SJ, Hallmen E, Reßle F, Gassmann H, Prexler C, Wawer A, von Luettichau I, Ladenstein R, Kazanowska B, Ljungman G, Niggli F, Lohi O, Hauer J, Gruhn B, Klingebiel T, Bader P, Burdach S, Lang P, Sparber-Sauer M, Koscielniak E, Thiel U. Schober SJ, et al. Among authors: von luettichau i. Front Oncol. 2022 May 10;12:878367. doi: 10.3389/fonc.2022.878367. eCollection 2022. Front Oncol. 2022. PMID: 35619911 Free PMC article.
46 results